Trending...
- Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI - 116
- Fact check: Claims swirling on California gas prices - 108
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty
~ ViaLase, Inc., a clinical-stage medical technology company, has recently received CE Mark approval in the European Union (EU) for its innovative ViaLase® Laser. This laser is designed to address unmet needs in the conventional glaucoma treatment paradigm and provide a non-invasive option for adult patients with primary open-angle glaucoma (POAG).
The ViaLase Laser combines the precision of a femtosecond laser with micron-level image guidance to deliver a procedure called femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT). This technology aims to offer patients a non-pharmacologic and incision-free alternative to traditional surgical procedures while still achieving their therapeutic goals.
According to Tibor Juhasz, PhD, Founder and Chief Executive Officer of ViaLase, Inc., the approval of the ViaLase Laser marks a significant advancement in interventional glaucoma care. He believes that this technology has the potential to deliver surgery-like results without the need for invasive procedures that can lead to complications. Early clinical data also suggests that FLigHT is safe and effective at lowering intraocular pressure (IOP).
More on The Californer
Richard Lewis, MD, Chief Medical Officer of ViaLase, Inc., also expressed his excitement about the approval of the ViaLase Laser. He believes that early intervention with non-medical treatments can offer better long-term disease control and preserve vision for patients. The advanced imaging and precision offered by this laser will bring a new level of care to glaucoma patients.
ViaLase plans to roll out the ViaLase Laser selectively in key markets later this year. The company has established partnerships with Global Surgical Service in Spain and Portugal and Teleon Surgical in Germany and Austria. These distributors have extensive experience in ophthalmology and established commercial presence in their respective markets. This strategic collaboration will ensure a timely and efficient introduction of the ViaLase Laser to physicians and patients.
It is important to note that the ViaLase Laser is not yet approved for use in the United States. However, with its CE Mark approval in the EU, it is expected to bring significant advancements in glaucoma treatment and improve the lives of patients worldwide.
The ViaLase Laser combines the precision of a femtosecond laser with micron-level image guidance to deliver a procedure called femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT). This technology aims to offer patients a non-pharmacologic and incision-free alternative to traditional surgical procedures while still achieving their therapeutic goals.
According to Tibor Juhasz, PhD, Founder and Chief Executive Officer of ViaLase, Inc., the approval of the ViaLase Laser marks a significant advancement in interventional glaucoma care. He believes that this technology has the potential to deliver surgery-like results without the need for invasive procedures that can lead to complications. Early clinical data also suggests that FLigHT is safe and effective at lowering intraocular pressure (IOP).
More on The Californer
- Live Courageously Hosts Ann-Marie Murrell, Author, Journalist, Former Political Commentator
- COSRX x Alfred Coffee Launch Skincare-Coffee Crossover
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Randall W. Lewis Center for Entrepreneurship Aims to Generate $1 Billion in Economic Impact by 2028
Richard Lewis, MD, Chief Medical Officer of ViaLase, Inc., also expressed his excitement about the approval of the ViaLase Laser. He believes that early intervention with non-medical treatments can offer better long-term disease control and preserve vision for patients. The advanced imaging and precision offered by this laser will bring a new level of care to glaucoma patients.
ViaLase plans to roll out the ViaLase Laser selectively in key markets later this year. The company has established partnerships with Global Surgical Service in Spain and Portugal and Teleon Surgical in Germany and Austria. These distributors have extensive experience in ophthalmology and established commercial presence in their respective markets. This strategic collaboration will ensure a timely and efficient introduction of the ViaLase Laser to physicians and patients.
It is important to note that the ViaLase Laser is not yet approved for use in the United States. However, with its CE Mark approval in the EU, it is expected to bring significant advancements in glaucoma treatment and improve the lives of patients worldwide.
Filed Under: Business
0 Comments
Latest on The Californer
- Official Launch Of 'The Ambony' Marks A New Era In Sophisticated Digital Society Platform
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- California: TOMORROW: Make America Rake Again: Governor Newsom to make announcement on new wildfire prevention strategy targeting federal lands
- California: TODAY: Governor Newsom to sign historic bills to create more housing and infrastructure – faster than ever before
- Can This Simple Test Predict How Long You'll Live?
- AI Performs Virtual Tissue Staining at Super-Resolution
- Online Distribution of the Summer 2025 Diamond Certified Directory Update Begins
- California: Governor Newsom proclaims Immigrant Heritage Month 2025
- California: Department of Defense agrees: it's time for Trump's militarization of Los Angeles to end
- Long Beach: City Launches Internet Service Enrollment Line
- Von Rock Law Founder Deidre Von Rock Named Super Lawyer for 2025
- California: Governor Newsom extends emergency short-term housing protections in Los Angeles
- Von Rock Law Named SFGate's Best Probate and Estate Attorney in 2025
- Long Beach to Conduct Annual Summer Recess for City Council Meetings During July
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
- Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
- Montessori Stoppani Partners with Lifetime Montessori School
- Cymbiotika Celebrates 2025 Great Place To Work Certification™
- Long Beach: LA28 Announces Finalized Sailing Venue Plan for 2028 Olympic Games
- Individual Software Announces New Versions of its Four Typing Programs in 2025